相关实验视频
Updated: Jun 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
关于1型糖尿病管理的患者相关结果:定性证据综合
Jessica Hanae Zafra-Tanaka1,2, Adela Del Valle1, Nathaly Aya Pastrana3
1CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
概括
开发1型糖尿病 (T1DM) 的核心结果集 (COS) 需要测量超越个体的结果. 这包括对护理人员,家庭和医疗保健系统的影响,以更好地管理T1DM.
科学领域:
- 内分泌学和新陈代谢学
- 患者报告的结果
- 医疗保健服务研究 医疗服务研究
背景情况:
- 1型糖尿病 (T1DM) 管理涉及个人及其支持系统.
- 现有的核心结果集 (COS) 通常只关注个体患者的结果.
- 需要对T1DM结果的全面了解,以告知以患者为中心的护理.
研究的目的:
- 确定和定义T1DM患者及其护理人员的关键结果.
- 探索不同背景和生命阶段的结果的变化.
- 为T1DM制定一个强大的核心成果集 (COS) 提供信息.
主要方法:
- 在主要数据库中对定性研究 (2010-2024) 进行了系统审查.
- 包括专注于T1DM患者和护理人员对护理和医疗保健的观点的研究.
- 用定性证据综合和患者咨询来确定结果.
主要成果:
- 分析了119项研究,其中大多数来自高收入国家.
- 结果被分为个人 (例如,糖尿病负担,倦怠),照顾者/家庭 (例如,负担,社会支持) 和系统级别 (例如,医疗保健准入,行政负担).
结论:
- 在个人,照顾者/家庭和系统层面存在T1DM结局.
- 目前的COS往往忽略了关怀者/家庭和系统因素,这些因素对T1DM至关重要.
- 一个全面的T1DM COS必须包含所有三个层次的结果,以满足患者和家庭的需求.
相关概念视频
Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156
Guidelines for Writing Outcome
2.7K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124

